الولايات المتحدة · وكالات وأخبار لحظية · PR Newswire

HanchorBio and Aston Sci Join Forces to Unlock the Potential of Next-Generation Immunotherapy Through Cancer Vaccine Combinations

نشره PR Newswire · الولايات المتحدة منذ 1 س

Strategic collaboration pairs HCB101 (macrophage CD47-SIRPα blockade) with Aston Sci's Phase 2 HER2-directed DNA vaccine (AST-301) to drive durable, dual innate/adaptive antitumor…

اقرأ المقال كاملًا على PR Newswire سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.prnewswire.com)

يستحق القراءة أيضًا

Business Wire

EOS and VOP CZ Sign Memorandum of Understanding to Explore Cooperation on Czech Programmes

Associated Press (Business)

Coastal construction projects threaten the mangrove forest that protects Vietnam’s biggest city

Dow Jones Newswires

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening

MT Newswires

HanchorBio and Aston Sci Join Forces to Unlock the Potential of Next-Generation Immunotherapy Through Cancer Vaccine Combinations

مشاركة

يستحق القراءة أيضًا

EOS and VOP CZ Sign Memorandum of Understanding to Explore Cooperation on Czech Programmes

Coastal construction projects threaten the mangrove forest that protects Vietnam’s biggest city

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows